CD8A and neoplasm: These differences in the composition of the tumor immune infiltrate also resulted in a significant decrease in the ratio of CD8+ T cells to Treg in the tumors of aged mice (Figure 2G, p=0.0007), a variable known to correlate with responsiveness to immuno-oncology therapies (15).